Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)
Chimeric antigen receptors redirect T cells (CAR-T) to target cancer cells. There are limited data characterizing cardiac toxicity and cardiovascular …
Related Articles
Nivolumab combined with brentuximab vedotin with or without mediastinal radiotherapy for relapsed/refractory primary mediastinal large B-cell lymphoma
Open access journal of the Ferrata-Storti Foundation, a non-profit organization Open access journal of the Ferrata-Storti Foundation, a non-profit organization Gustave Roussy, Université Paris-Saclay, Département…
Clinical Research Training in Hematology
The CRTH 2025 call for application will open April 2, 2024.What is Clinical Research Training in Hematology (CRTH)?[image src=”/assets/CRTH-logo-white-space.png” id=”6915″ width=”183″ height=”59″ class=”right ss-htmleditorfield-file image”]Clinical…
A fresh look at covalent BTK inhibitor resistance
In this issue of Blood, Woyach et al present a beautiful study of mutational profiling for patients with relapsed or refractory chronic lymphocytic leukemi
Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib
Key PointsBTK C481S was most common in both groups; in the acalabrutinib arm, low-VAF T474I (9/47; 8 co-occurring with C481S) but no L528W was seen.More…
Clinical Research Training in Hematology
The CRTH 2025 call for applications is open until September 24, 2024 (15:00 CEST).Apply nowWhat is Clinical Research Training in Hematology (CRTH)?Clinical Research Training in…
Geriatric assessment in oncology by Allison Magnuson et al. – OncoDaily
Geriatric assessment in oncology by Allison Magnuson et al. / Allison Magnuson, cancer, Erika Ramsdale, Erman Akkus, Fiona Stauffer, Grant R. Williams, Heidi
Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies
Chimeric antigen receptor (CAR) T-cell therapy causes serious side effects including cytokine release syndrome (CRS). CRS-related coagulopathy is associated with hypofibrinogenemia that has up to…
Nivolumab combined with brentuximab vedotin with or without mediastinal radiotherapy for relapsed/refractory primary mediastinal large B-cell lymphoma
Open access journal of the Ferrata-Storti Foundation, a non-profit organization Open access journal of the Ferrata-Storti Foundation, a non-profit organization Gustave Roussy, Université Paris-Saclay, Département…
Una campaña aplica la IA para mostrar los sentimientos de los pacientes con leucemia
Cada año se detectan en España cerca de 3.000 nuevos casos de leucemia linfocítica crónica, la leucemia más común y predominante en personas mayores. Un…
Analysis of @DrRaulCordoba FOLLOWERS
Mis seguidores viven en España(45%),Estados Unidos(22%),UK.(6%) y más tweepsmap.com/!DrRaulCordoba